Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano”) announces it has entered into a non-binding term sheet for a proposed business combination (“combination”) with Infinite Epigenetics™ (“Infinite Epigenetics,” “Infinite”), an artificial intelligence (“AI”)-powered preventive health and diagnostics company building a proprietary biological AI platform to read, interpret, and apply epigenetic signals at scale.
Read the full article: Nano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics Company //
Source: https://investors.nano-di.com/press-releases/news-details/2026/Nano-Dimension-Signs-Term-Sheet-with-Infinite-Epigenetics-to-Form-a-Publicly-Traded-AI-Powered-Preventive-Health-and-Diagnostics-Company/default.aspx